GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhoenixBio Co Ltd (TSE:6190) » Definitions » Price-to-Owner-Earnings

PhoenixBio Co (TSE:6190) Price-to-Owner-Earnings : (As of May. 28, 2025)


View and export this data going back to 2016. Start your Free Trial

What is PhoenixBio Co Price-to-Owner-Earnings?

As of today (2025-05-28), PhoenixBio Co's share price is 円366.00. PhoenixBio Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for PhoenixBio Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 10 years, the highest Price-to-Owner-Earnings of PhoenixBio Co was 10.77. The lowest was 9.72. And the median was 10.01.


TSE:6190's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-28), PhoenixBio Co's share price is 円366.00. PhoenixBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円3.29. Therefore, PhoenixBio Co's PE Ratio (TTM) for today is 111.31.

As of today (2025-05-28), PhoenixBio Co's share price is 円366.00. PhoenixBio Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円1.17. Therefore, PhoenixBio Co's PE Ratio without NRI for today is 313.09.

During the past 10 years, PhoenixBio Co's highest PE Ratio without NRI was 809.27. The lowest was 4.13. And the median was 22.70.


PhoenixBio Co Price-to-Owner-Earnings Historical Data

The historical data trend for PhoenixBio Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhoenixBio Co Price-to-Owner-Earnings Chart

PhoenixBio Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 10.77 -

PhoenixBio Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PhoenixBio Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, PhoenixBio Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Price-to-Owner-Earnings falls into.


;
;

PhoenixBio Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PhoenixBio Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=366.00/-32.37
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhoenixBio Co  (TSE:6190) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PhoenixBio Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PhoenixBio Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PhoenixBio Co Business Description

Traded in Other Exchanges
N/A
Address
3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.

PhoenixBio Co Headlines

No Headlines